Related Experiment Video
Updated: May 28, 2026
13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Genomic Medicine Among Ophthalmologists: Knowledge, Current Practice, and Barriers
Walaa Bakhamees1,2, Hend Alsafran1,3, Hani Basher ALBalawi4
1Vitreoretinal and Uveitis Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia.
Journal of Personalized Medicine
|May 26, 2026
Summary
Ophthalmologists in Saudi Arabia recognize the value of genomic medicine and genetic testing, but knowledge gaps persist. Integrating genetics into ophthalmology education is crucial for advancing precision medicine in the region.
Area of Science:
- Ophthalmology
- Genomic Medicine
- Precision Medicine
Background:
- Genomic medicine and genetic testing are increasingly vital in ophthalmology.
- Saudi Arabia is transitioning towards precision medicine.
- Assessing current ophthalmologist knowledge, attitudes, and practices is essential.
Purpose of the Study:
- To evaluate Saudi Arabian ophthalmologists' knowledge, attitudes, and practices regarding genomic medicine and genetic testing.
- To identify gaps in understanding and confidence in genetic testing applications.
- To inform curriculum development for genetics in ophthalmology.
Main Methods:
- A cross-sectional survey was distributed to ophthalmologists across Saudi Arabia.
- The questionnaire covered demographics, knowledge of genomics, confidence in genetic tasks, and attitudes toward genetic testing.
- Data were analyzed using descriptive and inferential statistics.
Main Results:
- 115 ophthalmologists participated, showing variable knowledge (e.g., high on inheritance patterns, low on DNA base-pairing).
- Confidence was highest in referrals and lowest in test selection/counseling.
- Most ophthalmologists held positive attitudes towards genetic testing but noted access difficulties and privacy concerns.
Conclusions:
- Saudi ophthalmologists acknowledge the importance of genetics in their field.
- Significant gaps in knowledge and familiarity with genomic medicine require attention.
- Integrating genetics into ophthalmology curricula is recommended to address these challenges.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...